SAFTY

Clinical trials for SAFTY explained in plain language.

Never miss a new study

Get alerted when new SAFTY trials appear

Sign up with your email to follow new studies for SAFTY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New injection Y-3 put to the test: will it clash with common drugs?

Knowledge-focused Completed

This completed Phase 1 trial in 24 healthy adults checked whether an experimental injection called Y-3 changes how the body handles three common drugs: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these drugs alone and …

Matched conditions: SAFTY

Phase: PHASE1 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:36 UTC

SAFTY

Get alerted when new SAFTY trials appear

New injection Y-3 put to the test: will it clash with common drugs?